The clinical-stage pharmaceutical company, Verrica Pharmaceuticals, is focused on creating proprietary topical treatments for lesional skin diseases like common warts, plantar warts, and Molluscum contagiosum. These conditions currently have limited treatment options that are either ineffective, painful, or require daily compliance for an extended period. Verrica Pharmaceuticals aims to provide novel treatments that offer significant benefits to individuals living with these skin diseases.